Tuesday, June 18, 2013

• EDAP Granted European Market Clearance for Focal.One(R)GlobeNewswire( (Tue, Jun 18)

Friday, June 14, 2013

• EDAP Fully Redeems $8.0 Million Long-Term DebtGlobeNewswire( (Fri, Jun 14)

Wednesday, May 29, 2013

• EDAP Significantly Strengthens Financial ProfileGlobeNewswire( (Wed, May 29)

Tuesday, May 21, 2013

• EDAP to Raise $12 Million in Registered Direct OfferingGlobeNewswire( (Tue, May 21)

Monday, May 20, 2013

• EDAP's Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year StudyGlobeNewswire( (Mon, May 20)

Thursday, May 16, 2013

• EDAP Reports 23% Increase in First Quarter 2013 RevenuesGlobeNewswire( (Thu, May 16)

Tuesday, May 14, 2013

• EDAP's Ablatherm-HIFU Receives Two Best Poster Awards at 2013 American Urological Association Annual MeetingGlobeNewswire( (Tue, May 14)

Monday, May 13, 2013

• EDAP Schedules Webcast and Conference Call for First Quarter 2013 ResultsGlobeNewswire( (Mon, May 13)

Wednesday, May 1, 2013

• EDAP Outlines Significant Participation at 2013 American Urological Association Annual MeetingGlobeNewswire( (Wed, May 1)

Thursday, April 11, 2013

• EDAP Announces 23% First Quarter 2013 Revenue GrowthGlobeNewswire( (Thu, Apr 11)

Tuesday, April 2, 2013

• EDAP Reports Fourth Quarter 2012 and Full Year ResultsGlobeNewswire( (Tue, Apr 2)

Thursday, March 28, 2013

• EDAP Receives U.S. FDA Filing Acceptance of Pre-Market Approval ApplicationGlobeNewswire( (Thu, Mar 28)